Baxiva is a biotechnology startup dedicated to developing next-generation glycoconjugate vaccines aimed at preventing infections caused by Gram-negative bacterial pathogens. Our lead vaccine candidate targets Escherichia coli, the leading cause of urinary tract infections globally and a significant contributor to antimicrobial resistance. Backed by cutting-edge science and located in Schlieren on ETH Zurich’s Hönggerberg campus, Baxiva offers a unique opportunity to contribute to high-impact science with real-world clinical potential.
As an in vivo associate at Baxiva, you will play a crucial role within our in vivo team. You will work hands-on in the animal facility conducting mouse experiments and testing various aspects of our vaccine. Your responsibilities will also include assay development and the evaluation of the immunological performance of vaccine components. This position will be based in the Mucosal Immunology research group on Hönggerberg, in close collaboration with the vaccine development team in Schlieren.
Your main responsibilities will include:
We are seeking someone who is curious, reliable, and delivers high-quality results while showing a strong eagerness to grow with us. You should thrive on tackling complex problems in a team setting to deliver real-world impact.
You bring:
We are a small, agile team of motivated scientists working in a friendly, collaborative environment where each member contributes their experience and expertise. We believe that science flourishes in an environment of open exchange, trust, and collaboration. We are committed to supporting the personal and professional growth of every team member.
Apply online using the form below. Only applications matching the job profile will be considered.
Location : Zürich ETH-Hönggerberg
Country : Switzerland